DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
AC-1204
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AC-1204
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEOSAXITOXIN
1
Small molecule
Investigational
Unknown
Unknown
Pain
Unknown
NEOSAXITOXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
6YRL8BWD9H
Molecule Type:
Small molecule
Molecular Formula:
C10H17N7O5
Molecular Weight:
315.29
AlogP:
-3.54
PSA:
193.75
HBD:
7.0
HBA:
#RotB:
2.0
Source:
SNX-001
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SNX-001
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PF-03814735
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora-A inhibitor
PF-03814735
×
Maximum Phase:
1
First Approval:
None
UNII:
6V5T4O5758
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
LENRISPODUN
1
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Systolic; Parkinson Disease; Schizophrenia
Unknown
LENRISPODUN
×
Maximum Phase:
1
First Approval:
None
UNII:
3GBO34D1BE
Molecule Type:
Small molecule
Molecular Formula:
C29H26FN7O
Molecular Weight:
507.57
AlogP:
5.06
PSA:
78.65
HBD:
1.0
HBA:
#RotB:
5.0
Source:
UC-781
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UC-781
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBASTINIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms
Tyrosine-protein kinase ABL inhibitor
REBASTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
75017Q6I97
Molecule Type:
Small molecule
Molecular Formula:
C30H28FN7O3
Molecular Weight:
553.6
AlogP:
6.05
PSA:
123.06
HBD:
3.0
HBA:
#RotB:
6.0
Source:
MAVATREP
1
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee
Vanilloid receptor antagonist
MAVATREP
×
Maximum Phase:
1
First Approval:
None
UNII:
F197218T99
Molecule Type:
Small molecule
Molecular Formula:
C25H21F3N2O
Molecular Weight:
422.45
AlogP:
6.65
PSA:
48.91
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BMS-394136
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-394136
×
Maximum Phase:
1
First Approval:
None
UNII:
M694U7167K
Molecule Type:
Small molecule
Molecular Formula:
C24H21Cl2FN4O
Molecular Weight:
471.36
AlogP:
5.98
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AR-42
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
AR-42
×
Maximum Phase:
1
First Approval:
None
UNII:
E0GG29V0AQ
Molecule Type:
Small molecule
Molecular Formula:
C18H20N2O3
Molecular Weight:
312.37
AlogP:
3.18
PSA:
78.43
HBD:
3.0
HBA:
#RotB:
5.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OMIPALISIB
1
Small molecule
Investigational
Unknown
Unknown
Idiopathic Pulmonary Fibrosis; Neoplasms
PI3-kinase class I inhibitor
OMIPALISIB
×
Maximum Phase:
1
First Approval:
None
UNII:
1X8F5A3NA0
Molecule Type:
Small molecule
Molecular Formula:
C25H17F2N5O3S
Molecular Weight:
505.51
AlogP:
4.84
PSA:
106.96
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CLENBUTEROL
1
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Glycogen Storage Disease Type II; Parkinson Disease; Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
CLENBUTEROL
×
Maximum Phase:
1
First Approval:
None
UNII:
XTZ6AXU7KN
Molecule Type:
Small molecule
Molecular Formula:
C12H18Cl2N2O
Molecular Weight:
277.2
AlogP:
3.0
PSA:
58.28
HBD:
3.0
HBA:
#RotB:
3.0
Source:
MOFAROTENE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Retinoid receptor modulator
MOFAROTENE
×
Maximum Phase:
1
First Approval:
None
UNII:
8K3CVY8F8V
Molecule Type:
Small molecule
Molecular Formula:
C29H39NO2
Molecular Weight:
433.64
AlogP:
6.31
PSA:
21.7
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SC-43
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
SC-43
×
Maximum Phase:
1
First Approval:
None
UNII:
OT4AQX5MLU
Molecule Type:
Small molecule
Molecular Formula:
C21H13ClF3N3O2
Molecular Weight:
431.8
AlogP:
6.67
PSA:
74.15
HBD:
2.0
HBA:
#RotB:
4.0
Source:
AZD-6482
1
Small molecule
Investigational
Unknown
Unknown
Unknown
PI3-kinase class I inhibitor
AZD-6482
×
Maximum Phase:
1
First Approval:
None
UNII:
78G6MP5PZ5
Molecule Type:
Small molecule
Molecular Formula:
C22H24N4O4
Molecular Weight:
408.46
AlogP:
2.71
PSA:
96.17
HBD:
2.0
HBA:
#RotB:
5.0
Source:
IMD-0354
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-0354
×
Maximum Phase:
1
First Approval:
None
UNII:
76145IS906
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E-7820
1
Small molecule
Investigational
Unknown
Unknown
Colonic Neoplasms; Lymphoma; Neoplasms; Rectal Neoplasms
Unknown
E-7820
×
Maximum Phase:
1
First Approval:
None
UNII:
TVH5K7949N
Molecule Type:
Small molecule
Molecular Formula:
C17H12N4O2S
Molecular Weight:
336.38
AlogP:
3.02
PSA:
109.54
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LY2979165
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder
Metabotropic glutamate receptor 2 agonist
LY2979165
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
DM-1157
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
DM-1157
×
Maximum Phase:
1
First Approval:
None
UNII:
6X58GJ0RMS
Molecule Type:
Small molecule
Molecular Formula:
C28H31ClN6
Molecular Weight:
487.05
AlogP:
5.32
PSA:
65.97
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LHF-535
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LHF-535
×
Maximum Phase:
1
First Approval:
None
UNII:
BET7FM8SQG
Molecule Type:
Small molecule
Molecular Formula:
C27H28N2O2
Molecular Weight:
412.53
AlogP:
6.21
PSA:
47.28
HBD:
1.0
HBA:
#RotB:
6.0
Source:
XL-418
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Ribosomal protein S6 kinase (P70S6K) inhibitor
XL-418
×
Maximum Phase:
1
First Approval:
None
UNII:
OLJ18SRI8A
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
DIAMORPHINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIAMORPHINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
1
2
…
67
68
69
70
71
72
73
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA